These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 22104451

  • 1. Single-pill triple-combination therapy: an alternative to multiple-drug treatment of hypertension.
    Chrysant SG.
    Postgrad Med; 2011 Nov; 123(6):21-31. PubMed ID: 22104451
    [Abstract] [Full Text] [Related]

  • 2. The single pill triple combination of aliskiren, amlodipine, and hydrochlorothiazide in the treatment of hypertension.
    Huan Y, Townsend R.
    Expert Opin Pharmacother; 2012 Nov; 13(16):2409-15. PubMed ID: 23067322
    [Abstract] [Full Text] [Related]

  • 3. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 4. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension.
    Frampton JE, Scott LJ.
    Am J Cardiovasc Drugs; 2009 Feb; 9(5):309-30. PubMed ID: 19791840
    [Abstract] [Full Text] [Related]

  • 5. Blood pressure control with angiotensin receptor blocker-based three-drug combinations: key trials.
    de la Sierra A, Barrios V.
    Adv Ther; 2012 May; 29(5):401-15. PubMed ID: 22610686
    [Abstract] [Full Text] [Related]

  • 6. Amlodipine/valsartan/hydrochlorothiazide: fixed-dose combination in hypertension.
    Deeks ED.
    Am J Cardiovasc Drugs; 2009 May; 9(6):411-8. PubMed ID: 19929039
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J, Shojaee A, Maa JF.
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [Abstract] [Full Text] [Related]

  • 8. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA, Crikelair NA, Yen J, Glazer RD.
    Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
    [Abstract] [Full Text] [Related]

  • 9. Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in Hispanic/Latino patients with hypertension: the TRINITY study.
    Lewin AJ, Kereiakes DJ, Chrysant SG, Izzo JL, Oparil S, Lee J, Fernandez V, Melino M.
    Ethn Dis; 2014 Nov; 24(1):41-7. PubMed ID: 24620447
    [Abstract] [Full Text] [Related]

  • 10. Valsartan-amlodipine-hydrochlorothiazide: the definitive fixed combination?
    Barrios V, Escobar C.
    Expert Rev Cardiovasc Ther; 2010 Nov; 8(11):1609-18. PubMed ID: 21090936
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of amlodipine/olmesartan medoxomil ± HCTZ in obese patients uncontrolled on antihypertensive monotherapy.
    Hsueh WA, Shojaee A, Maa JF, Neutel JM.
    Curr Med Res Opin; 2012 Nov; 28(11):1809-18. PubMed ID: 23072496
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV.
    Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
    [Abstract] [Full Text] [Related]

  • 13. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers.
    Vaidyanathan S, Valencia J, Kemp C, Zhao C, Yeh CM, Bizot MN, Denouel J, Dieterich HA, Dole WP.
    Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832
    [Abstract] [Full Text] [Related]

  • 14. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S.
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [Abstract] [Full Text] [Related]

  • 15. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II receptor blocker combinations: from guidelines to clinical practice.
    Narkiewicz K.
    Blood Press; 2012 Apr; 21(2):73-81. PubMed ID: 21830845
    [Abstract] [Full Text] [Related]

  • 17. Hypertension management: rationale for triple therapy based on mechanisms of action.
    Neutel JM, Smith DH.
    Cardiovasc Ther; 2013 Oct; 31(5):251-8. PubMed ID: 23121769
    [Abstract] [Full Text] [Related]

  • 18. Olmesartan/amlodipine/hydrochlorothiazide in participants with hypertension and diabetes, chronic kidney disease, or chronic cardiovascular disease: a subanalysis of the multicenter, randomized, double-blind, parallel-group TRINITY study.
    Kereiakes DJ, Chrysant SG, Izzo JL, Littlejohn T, Melino M, Lee J, Fernandez V, Heyrman R.
    Cardiovasc Diabetol; 2012 Oct 30; 11():134. PubMed ID: 23110471
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of aliskiren 300  mg/hydrochlorothiazide 25  mg (± amlodipine 5  mg) in hypertensive patients not controlled by candesartan 32  mg plus HCT 25  mg.
    Schweizer J, Ulmer HJ, Benduhn H, Klebs S.
    Curr Med Res Opin; 2011 Jan 30; 27(1):131-40. PubMed ID: 21117946
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.
    Volpe M, Christian Rump L, Ammentorp B, Laeis P.
    Clin Drug Investig; 2012 Oct 01; 32(10):649-64. PubMed ID: 22909147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.